NCT06118554 3D Printing to Improve Nasal Irrigation Outcome
| NCT ID | NCT06118554 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Ohio State University |
| Condition | Chronic Rhinosinusitis With Nasal Polyps |
| Study Type | INTERVENTIONAL |
| Enrollment | 200 participants |
| Start Date | 2021-11-01 |
| Primary Completion | 2027-06-26 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 200 participants in total. It began in 2021-11-01 with a primary completion date of 2027-06-26.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Three-dimensional (3D) printing has been an emerging technology with uses in a wide array of fields. This research aims to use 3D printing as a tool to provide personalized education to maximize treatment efficacy based on the patient's individual anatomy. With increased irrigation to the sinuses, we hypothesize there will be improved patient satisfaction and higher quality of life. The outcomes of this research could lead to a new option for patients who live with chronic rhinosinusitis are not candidates for surgery or are interested in less invasive options. The 3D printed nasal replica is not something that would be implanted, rather it is a hand-held device used specifically for participants to better understand their nasal anatomy.
Eligibility Criteria
Inclusion Criteria: * Chronic rhinosinusitis without nasal polyps (CRSsNP) or Chronic rhinosinusitis with nasal polyps (CRSwNP). Exclusion Criteria: * Patients with significant nasal polyps (as determined by a clinician) were excluded upfront due to the unlikeness of irrigation penetration regardless of the head position. Patients with significant atopy, cystic fibrosis, granulomatosis with polyangiitis or other connective tissue disorder, and current pregnancy were also excluded.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06118554 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 75 Years, studying Chronic Rhinosinusitis With Nasal Polyps. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06118554 currently recruiting?
Yes, NCT06118554 is actively recruiting participants. Contact the research team at zhao.1949@osu.edu for enrollment information.
Where is the NCT06118554 trial being conducted?
This trial is being conducted at Columbus, United States.
Who is sponsoring the NCT06118554 clinical trial?
NCT06118554 is sponsored by Ohio State University. The trial plans to enroll 200 participants.